Wenjun Wang

3.0k citations
70 papers · 2.0k · 2 hit papers · h-index 24

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis

Papers in

    • Glycosylation and Glycoproteins Research 5
    • Epigenetics and DNA Methylation 4
    • Melanoma and MAPK Pathways 3
    • Cytokine Signaling Pathways and Interactions 5
    • Cancer Immunotherapy and Biomarkers 5
    • Cancer Cells and Metastasis 4

Wenjun Wang

66 papers receiving 2.0k citations

Hit Papers

Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer 2021 · 177 citations
1770+1+3Years since publication50100150

Peers

Wenjun Wang
Comparison fields: 5 of 127
  • Cancer Research 298
  • Oncology 538
  • Geriatrics and Gerontology 66
  • Immunology 348
  • Rehabilitation 109
Replace Rezvan Najafi with:
Rezvan Najafi Iran
Wen‐Sheng Wu Taiwan
Bingwen Zou China
Ji‐Young Lee South Korea
Prashant Trikha United States
Tianhui Hu China
Kai Qu China
Yu Zhu China
Zhongquan Qi China
Wenjun Wang relative to Rezvan Najafi Iran Rezvan Najafi's profile →
Citations per field
00.5×3.0×
Rezvan Najafi · 1×
Citations per year

Countries citing papers authored by Wenjun Wang

Since Specialization
Citations

This map shows the geographic impact of Wenjun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun Wang more than expected).

Fields of papers citing papers by Wenjun Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun Wang. The network helps show where Wenjun Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Wenjun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wenjun Wang Line = papers co-authored together Wenjun Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Biodegradable hydrogel with thermo-response and hemostatic effect for photothermal enhanced anti-infective therapy
Hit paper breakdown →
2021185
2 2012177
3
Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer
Hit paper breakdown →
2021177
4 2008143
5 2017120
6 202093
7 200788
8 201572
9 202364
10 200545
11 202342
12 202237
13 201335
14 202034
15 202133
16 201733
17 200832
18 202331
19 202030
20 201329

About Wenjun Wang

Wenjun Wang is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Immunology and Cancer Research, having authored 70 papers that have together received 2.0k indexed citations. Recurring topics across this work include Carbohydrate Chemistry and Synthesis (6 papers), Cytokine Signaling Pathways and Interactions (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Glycosylation and Glycoproteins Research (5 papers), Epigenetics and DNA Methylation (4 papers), Cancer Cells and Metastasis (4 papers), Melanoma and MAPK Pathways (3 papers) and Wound Healing and Treatments (3 papers). The work is most often cited by research in Cancer Research (298 citations), Oncology (538 citations), Geriatrics and Gerontology (66 citations), Immunology (348 citations) and Rehabilitation (109 citations). Wenjun Wang has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Si-Pei Wu, Yongsheng Shi, Ya‐Jia Xie, Zebo Jiang, Kai‐Tai Yao, Qibiao Wu, Elaine Lai‐Han Leung, Jumin Huang, Xing‐Xing Fan and Qianbing Zhang. Their work appears in journals such as Pharmacological Research, Clinical Cancer Research, Chemical Engineering Journal, RSC Advances and Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact